CTI BioPharma Corp

NASDAQ:CTIC   12:20:58 PM EDT
3.00
-0.10 (-3.23%)
Debt Financing / Related, Products, Regulatory

CTI Biopharma And DRI Healthcare Announce Up To $135 Mln Transaction

Published: 08/25/2021 11:37 GMT
CTI BioPharma Corp (CTIC) - Cti Biopharma and Dri Healthcare Trust Announce Up to $135 Million Debt and Royalty Transaction.
Dri Healthcare Trust - Transaction to Fund Launch, Commercialization of Pacritinib in U.S. in 2021 Pending FDA Approval, and Future Commercialization.
Dri Healthcare Trust - to Provide $50 Million Credit Facility at Closing, Will Also Provide Cti With $60 Million on Receiving Accelerated Approval of Pactritinib.